Get the Stockscreener App
1.75
1.74%
0.03
After Hours:
1.75
Hillevax Inc stock is traded at $1.75, with a volume of 62,281.
It is up +1.74% in the last 24 hours and down -6.91% over the past month.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.
See More
Previous Close:
$1.72
Open:
$1.73
24h Volume:
62,281
Relative Volume:
0.30
Market Cap:
$87.16M
Revenue:
-
Net Income/Loss:
$-123.57M
P/E Ratio:
-0.5757
EPS:
-3.04
Net Cash Flow:
$-97.53M
1W Performance:
-1.13%
1M Performance:
-6.91%
6M Performance:
-3.31%
1Y Performance:
-89.96%
1-Day Range:
$1.71
$1.785
1-Week Range:
$1.70
$1.81
52-Week Range:
$1.55
$17.36
Hillevax Inc Stock (HLVX) Company Profile
Name
Hillevax Inc
Sector
Industry
Phone
(617) 213-5054
Address
321 HARRISON AVE, SUITE 500, BOSTON
Compare HLVX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HLVX
Hillevax Inc
|
1.75 | 87.16M | 0 | -123.57M | -97.53M | -3.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
512.52 | 131.61B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.36 | 73.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
619.97 | 37.67B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.44 | 32.81B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
266.26 | 28.62B | 3.81B | -644.79M | -669.77M | -6.24 |
Hillevax Inc Stock (HLVX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-09-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jul-09-24 | Downgrade | Stifel | Buy → Hold |
| Jul-08-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-13-23 | Initiated | H.C. Wainwright | Buy |
View All
Hillevax Inc Stock (HLVX) Latest News
HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World
HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq
HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World
HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire
Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria
Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News
Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World
Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat
Top Executives Cash In on HilleVax Stock Sales - TipRanks
HilleVax Executives Sell Shares in February 2025 - TradingView
Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World
HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire
HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World
Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Geode Capital Management LLC - Defense World
Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Critical Comparison: Zura Bio (NASDAQ:ZURA) versus HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by State Street Corp - Defense World
Cancer Vaccine Breaking News - Vax-Before-Travel
Short Interest in HilleVax, Inc. (NASDAQ:HLVX) Expands By 7.4% - MarketBeat
Charles Schwab Investment Management Inc. Has $133,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
Critical Survey: Fate Therapeutics (NASDAQ:FATE) versus HilleVax (NASDAQ:HLVX) - Defense World
Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World
HilleVax, Inc. Announces Management Changes - Marketscreener.com
3 US Penny Stocks With Market Caps Under $100M - Simply Wall St
HilleVax initiates major workforce reduction, executives depart By Investing.com - Investing.com Australia
HilleVax initiates major workforce reduction, executives depart - Investing.com
HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MarketWatch
HilleVax, Inc. Announces Workforce Reduction and Leadership Changes - TipRanks
Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World
JP Morgan Downgrades HilleVax (HLVX) - MSN
1,064,000 Shares in HilleVax, Inc. (NASDAQ:HLVX) Bought by Braidwell LP - MarketBeat
GSA Capital Partners LLP Acquires New Shares in HilleVax, Inc. (NASDAQ:HLVX) - Defense World
England's Norovirus Outbreak Peaks Early in 2024 - Precision Vaccinations
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update - MarketBeat
HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% on Disappointing Earnings - Defense World
HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% Following Weak Earnings - MarketBeat
HilleVax Reports Q3 Financial Results Amid Strategic Planning - TipRanks
HilleVax Inc. (HLVX) Quarterly 10-Q Report - Quartzy
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress - The Manila Times
Rave Restaurant Group And 2 Other Promising US Penny Stocks - Simply Wall St
HilleVax, Inc. (NASDAQ:HLVX) Receives $9.20 Average PT from Analysts - Defense World
What Makes HilleVax (HLVX) a New Buy Stock - MSN
HilleVax announces workforce reduction to cut costs - Investing.com India
Hillevax Inc Stock (HLVX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):